Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$17,500.00
Novel Approaches to Treat Age-Related Macular Degeneration
FY 2013-14
Summary
Age-Related Macular Degeneration (AMD) is a disease of the eye that is the leading cause of blindness for people over the age of 50 years. It manifests as a loss of detailed central vision – the ability to do fine, sharp visual tasks such as read and recognize faces. There are two forms of AMD that exist; ‘dry’ AMD and ‘wet’ AMD. Various treatment options are available for ‘wet’ AMD. However, ‘wet’ AMD accounts for only 10% of all AMD cases. There are no treatment options available for ‘dry’ AMD which accounts for the other 90% of cases. Although the biological events that lead to AMD are not completely understood, it is thought that a major contributor to its development is unregulated complement system activation. The complement system is a series of reactions involving enzymes – proteins that speed up chemical reactions – that is part of our body’s automatic defensive response. Our lab has recently identified a complement system-suppressing function of a molecule called polyphosphate (polyP) through a series of in vitro studies (conducted outside a living body). PolyP is a molecule that is found in all cells of all organisms. Its function in microbes such as bacteria, is diverse and well-characterized. However, it is only recently that their function in human cells is becoming evident. Notably, we have conducted a preliminary in vivo (conducted within a living body) study in rodents that showed that the damage associated with AMD are could be prevented if polyP was injected into the eye. Based on these findings, we hypothesize that treatments with polyP will protect against the development and progression of both ‘dry’ and ‘wet’ AMD. To test this, my Master’s project will focus on two approaches. The first will be to check the protective properties of polyP against stresses to the cells that are specifically damaged in AMD. The other approach is to evaluate how well the progression of AMD can be minimized by injecting polyP into the eyes of rodents, similar to the preliminary study. The results of this project will bring to light the ccurrently unknown biological processes that lead to AMD, and potentially offer a new treatment option for both forms of the disease. This will be of enormous value to the AMD field and to the millions of people who are bound to develop this disease.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
311942
Name
Ocariza Linnette M
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Novel Approaches to Treat Age-Related Macular Degeneration
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Age-Related Macular Degeneration; Aging; Complement System; Novel Therapeutics; Polyphosphate
Abstract
Age-Related Macular Degeneration (AMD) is a disease of the eye that is the leading cause of blindness for people over the age of 50 years. It manifests as a loss of detailed central vision – the ability to do fine, sharp visual tasks such as read and recognize faces. There are two forms of AMD that exist; ‘dry’ AMD and ‘wet’ AMD. Various treatment options are available for ‘wet’ AMD. However, ‘wet’ AMD accounts for only 10% of all AMD cases. There are no treatment options available for ‘dry’ AMD which accounts for the other 90% of cases. Although the biological events that lead to AMD are not completely understood, it is thought that a major contributor to its development is unregulated complement system activation. The complement system is a series of reactions involving enzymes – proteins that speed up chemical reactions – that is part of our body’s automatic defensive response. Our lab has recently identified a complement system-suppressing function of a molecule called polyphosphate (polyP) through a series of in vitro studies (conducted outside a living body). PolyP is a molecule that is found in all cells of all organisms. Its function in microbes such as bacteria, is diverse and well-characterized. However, it is only recently that their function in human cells is becoming evident. Notably, we have conducted a preliminary in vivo (conducted within a living body) study in rodents that showed that the damage associated with AMD are could be prevented if polyP was injected into the eye. Based on these findings, we hypothesize that treatments with polyP will protect against the development and progression of both ‘dry’ and ‘wet’ AMD. To test this, my Master’s project will focus on two approaches. The first will be to check the protective properties of polyP against stresses to the cells that are specifically damaged in AMD. The other approach is to evaluate how well the progression of AMD can be minimized by injecting polyP into the eyes of rodents, similar to the preliminary study. The results of this project will bring to light the ccurrently unknown biological processes that lead to AMD, and potentially offer a new treatment option for both forms of the disease. This will be of enormous value to the AMD field and to the millions of people who are bound to develop this disease.
Competitiondate
201312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ocariza, Linnette M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~